Press release
Japan Software as a Medical Device Market is growing at a CAGR of 17.3% - Driven by Aging Population and Rising Adoption of AI-Powered Remote Healthcare Solutions | DataM Intelligence
Japan Software as a Medical Device
Download Free sample report:-https://www.datamintelligence.com/download-sample/japan-software-as-a-medical-device-market?pratik
Recent Industry Development in Japan market:
✅ Japan accounts for about 6-7% of the global SaMD market, supported by rapid digitization of healthcare systems and regulatory modernization.
✅ Japan's Pharmaceuticals and Medical Devices Agency (PMDA) has accelerated approvals for AI-powered diagnostic SaMD, especially in imaging (CT/MRI analysis), ophthalmology, and oncology decision-support.
✅ Integration of SaMD with Japan's national telemedicine expansion has increased adoption of remote patient management solutions for chronic diseases such as diabetes, cardiac disorders, and elderly care.
✅ Japan's aging population (nearly 30% above age 65) has driven high demand for SaMD tools supporting fall detection, cognitive decline monitoring, and home-based digital diagnostics.
✅ Government initiatives under the Digital Health Promotion Program encourage development of interoperable, cloud-enabled SaMD systems that align with smart hospitals and AI-enabled care pathways.
Recent Industry Development in U.S market:
✅ U.S. SaMD market is one of the largest globally, accounting for an estimated 38-40% share of global SaMD revenues in 2024, driven by strong regulatory clarity and digital health adoption.
✅ The U.S. Software as a Medical Device market was valued at around USD 2.9 billion in 2024 and is projected to reach USD 6.7 billion by 2030, registering a CAGR of about 14.8% (2025-2030).
✅ Rapid FDA approvals under the Digital Health Center of Excellence, including AI-based diagnostic tools, remote monitoring platforms, and chronic disease management software, have accelerated market growth.
✅ Strong adoption of AI/ML SaMD, including radiology imaging tools, cardiology decision-support software, and diabetes monitoring algorithms, supported by cloud integration and interoperability standards (FHIR).
✅ Major technology-healthcare partnerships (e.g., med-tech companies partnering with cloud vendors like AWS, Microsoft, Google) are expanding SaMD R&D capacity and reducing time-to-market.
Key Investment
➠ SoftBank Group (Japan / U.S.): Launched a joint venture with Tempus (U.S.) in June 2024 to bring AI-driven clinical/genomic data services to Japan; each party committed about ¥15 billion (USD 93 million) to the venture, signalling large strategic investments into medical software/AI services for the Japanese market.
➠ Fujifilm (Japan): Stepped up enterprise imaging and AI software investments as part of a major healthcare capex push Fujifilm reported capital investments in healthcare exceeding ¥600 billion (fiscal 2024), underlining corporate investment into SaMD and imaging software.
➠ Japanese government / regulators (MHLW, PMDA, JETRO): Active funding, guidance and fast-track initiatives to support SaMD/AI medical device development these public investments and regulatory programs are lowering barriers and attracting private capital into Japanese SaMD startups and partnerships.
➠ Private equity & market research signals: Market research firms and transaction trackers report accelerating M&A, strategic minority investments and growing PE interest as the Japan SaMD market scales (market estimated at USD 19.6 million in 2024 with high CAGR expectations), which together indicate increasing deal activity and funding opportunities for SaMD companies in Japan.
Benefits of AI for the Japan Software as a Medical Device Market
➠Enhanced diagnostic accuracy through AI-driven image analysis, reducing false positives and improving early disease detection.
➠Personalized treatment recommendations using machine-learning algorithms trained on large Japanese patient datasets.
➠Faster clinical decision-making with real-time AI insights integrated into hospital IT systems.
➠Automation of routine monitoring tasks, improving efficiency in chronic disease management such as diabetes and cardiac care.
➠Predictive analytics for early detection of patient deterioration and risk assessment.
➠Improved workflow efficiency for clinicians through AI-enabled triage, alerts, and prioritization tools.
➠Reduced human error in data interpretation, medication dosing support, and digital prescriptions.
"Secure your 30% year-end discount - get this report before the offer expires."
:https://www.datamintelligence.com/buy-now-page?report=japan-software-as-a-medical-device-market?pratik ((Purchase 2 or more Repots and get 50% Discount)
Segmentation Analysis :
By Application:
➠ Disease Management: Leading segment driven by adoption of AI-enabled tools for chronic care and remote monitoring.
➠ Diagnostics: Strong growth supported by imaging analysis, early detection, and decision-support software.
➠ Treatment Monitoring: Expanding demand for continuous therapy tracking and real-time clinical alerts.
➠ Predictive Health Analytics: Rising adoption as insurers and providers move toward preventive care models.
➠ Others: Includes workflow automation and personalized therapy planning with gradually increasing uptake.
By Indication:
➠ Diabetes: Dominant segment due to rising diabetic population and high use of digital glucose-monitoring and insulin-management software.
➠ Mental Health: Significant share driven by digital therapeutics and remote psychological support tools.
➠ Oncology: Growing adoption of software for tumor detection, treatment planning, and genomic analysis.
➠ Cardiovascular: Notable share supported by ECG-analysis and heart-condition monitoring SaMD solutions.
➠ Respiratory Conditions: Steady demand for COPD and asthma management apps.
➠ Others: Includes neurology, musculoskeletal care, and additional emerging digital-health applications.
Regional Insights:
➠Asia-Pacific: Fastest-growing region, led by rapid digitalization in China, India and Japan, expanding telehealth, and strong uptake of AI/cloud-based SaMD APAC shows higher CAGR projections vs other regions. Japan is a key growth country within APAC due to aging population and government support for med-tech innovation.
➠North America: Largest global market, holding the biggest share in 2024 thanks to heavy private & public healthcare R&D spending, advanced digital-health adoption, strong reimbursement pathways, and large vendor presence driving enterprise deployments.
➠Europe: Mature market with steady growth; emphasis on regulatory alignment (MDR/IVDR-style oversight), data privacy, clinical validation and interoperability. Growth is more measured and driven by compliance-led product launches and established healthcare systems.
Growth drivers:
Rapid aging population increasing demand for remote healthcare solutions.
Growing adoption of AI-powered diagnostics and digital therapeutics.
Government initiatives supporting digital health and fast-track approvals for AI-based devices.
Integration of cloud and IoT for real-time patient monitoring and early disease detection.
Strategic collaborations and investments in healthcare AI and wearable device solutions.
Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/japan-software-as-a-medical-device-market?pratik
Key players:
F. Hoffmann-La Roche Ltd, Abbott Laboratories, Medtronic plc, Terumo Corporation, B. Braun SE, Merck & Co., Inc., Novo Nordisk A/S., Eli Lilly and Company, Boehringer Ingelheim Pharmaceuticals, Inc and Insulet Corporation.
Key highlights:
➠ F. Hoffmann-La Roche Ltd
A major contributor to Japan's SaMD landscape with strong capabilities in digital diagnostics and algorithm-based disease detection. Roche's integration of AI-driven clinical decision support tools enhances precision diagnostics, strengthening its presence across oncology and chronic disease management applications in Japan.
➠ Abbott Laboratories
Well-positioned in Japan through its expanding portfolio of connected health solutions, especially glucose monitoring and cardiovascular diagnostic software. Abbott's emphasis on real-time patient monitoring and cloud-based data analytics supports the country's shift toward remote healthcare and continuous disease management.
➠ Medtronic plc
A prominent player leveraging advanced therapeutic monitoring and AI-enabled software for cardiovascular and diabetes-related conditions. Medtronic's focus on interoperable medical software platforms boosts hospital adoption in Japan, enhancing patient management efficiency and device-software integration.
➠ Terumo Corporation
A leading domestic player driving innovation in clinical workflow optimization, diagnostic support systems, and imaging-guided software. Terumo's localized R&D and strong hospital relationships enable rapid adoption of SaMD solutions tailored to Japan's regulatory and clinical environment, reinforcing its strategic market influence.
Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?pratik
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insightsthrough pricing analysis, market share breakdowns, and competitive intelligence. Thecompany specializes in strategic reports that guide businesses in high-growth sectors suchas nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter,LinkedIn and Facebook.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Japan Software as a Medical Device Market is growing at a CAGR of 17.3% - Driven by Aging Population and Rising Adoption of AI-Powered Remote Healthcare Solutions | DataM Intelligence here
News-ID: 4279569 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
US Esomeprazole Market Projected to Grow at 6.16% CAGR from 2025 to 2030, Suppor …
Leander, Texas and TOKYO, Japan - The United States Esomeprazole Market is valued at approximately USD 1.94 billion in 2025 and is projected to reach about USD 2.71 billion by 2030, growing at a CAGR of around 6.16% during the forecast period from 2025 to 2030.
This growth is driven by increasing prevalence of gastroesophageal reflux disease (GERD) and related gastrointestinal disorders in the US, widespread diagnosis and insurance coverage, and…
U.S. Remote Browser Isolation Market to Grow at 29.2% CAGR, Led by FireEye, Menl …
The U.S. Remote Browser Isolation Market was valued at US$ 0.10 billion in 2024 and is projected to grow steadily at a CAGR of around 29.2% over the forecast period. Growth is supported by rising cyberattacks, large-scale cloud adoption, and the expanding remote and hybrid workforce that requires secure, isolated browsing environments to prevent web-based threats.
The market maintains a strong position in the U.S. cybersecurity ecosystem, with increasing adoption across…
US Business Process Outsourcing Market Projected to Grow at 10.39% CAGR from 202 …
Leander, Texas and TOKYO, Japan - The United States Business Process Outsourcing Market is valued at approximately USD 130.84 billion in 2024 and is projected to reach about USD 351.59 billion by 2034, growing at a CAGR of around 10.39% during the forecast period from 2025 to 2034.
This strong growth is driven by increasing demand for BPO services across IT, finance, healthcare, and customer service sectors, fueled by digital transformation…
United States Diabetes Care Drugs & Devices Market is to reach US$ 244.46 billio …
Global Diabetes Care Drugs & Devices Market reached US$ 119.86 billion in 2024 and is expected to reach US$ 244.46 billion by 2033, growing at a CAGR of 8.3% during the forecast period 2025-2033.
Download Free sample report:-https://www.datamintelligence.com/download-sample/diabetes-care-drugs-and-devices-market?pratik
Recent Industry Development in U.S market:
✅ The U.S. diabetes care drugs & devices market is projected to grow from US$ 62.52 billion in 2025 to US$ 76.15 billion by 2030, at a CAGR…
More Releases for Japan
Vision Guided Robotic Systems Market Size 2022 - FANUC(Japan), KUKA(Germany), AB …
The Vision Guided Robotic Systems Market research report also provides an in-depth analysis of key players in the market, including their company profiles, business offerings, recent development, market strategies, and critical observation related to the product. The research study provides extensive coverage of the Vision Guided Robotic Systems Market size across all industries and businesses. In addition, it offers detailed insights into market size and growth depending upon various segments…
Japan Agriculture Market, Japan Agriculture Industry, Japan Agriculture Livestoc …
The agriculture sector is a very significant sector in Japan. Agriculture sector exists in every part of country, but is especially essential on the northern island of Hokkaido that accounts for approximately 10% of national production. Modern methods such as commercial fertilizers, hybrid seeds, insecticides, and machinery, have been used so efficiently in farming. Japan is the second major agricultural product importer in the world (after the U.S.). Almost all…
Car Navigation ECU Market 2019: Top Key Players are AW Software (Japan), Contine …
Car Navigation ECU Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry.
Get Sample Copy of this Report@ https://www.researchreportsworld.com/enquiry/request-sample/13844912
Global Car Navigation ECU market 2019 research provides a basic overview of the industry…
Global Car Navigation ECU Market Outlook to 2023 – AW Software (Japan), Contin …
An automotive navigation system is part of the automobile controls or a third party add-on used to find direction in an automobile and the ECU is the core part control it.
Car Navigation typically uses a satellite navigation device to get its position data which is then correlated to a position on a road. According to this study, over the next five years the Car Navigation ECU market will register a…
Global Car Navigation Parts Market Research Report 2019-2025 | Global Key Play …
This research report titled “Global Car Navigation Parts Market” Insights, Forecast to 2025 has been added to the wide online database managed by Market Research Hub (MRH). The study discusses the prime market growth factors along with future projections expected to impact the Car Navigation Parts Market during the period between 2018 and 2025. The concerned sector is analyzed based on different market factors including drivers, restraints and opportunities in…
Global Automotive 3D Scanning Laser Radar (3D-LiDAR) Market 2019-2025 | Velodyne …
Researchmoz added Most up-to-date research on "Global Automotive 3D Scanning Laser Radar (3D-LiDAR) Market Insights,Forecast to 2025" to its huge collection of research reports.
3D LiDAR uses a pulsed laser to detect distance, velocity and angle with high precision. LiDAR can classify objects, detect lane markings, and may also be used to accurately position an autonomous vehicle relative to a high definition map.
3D LiDAR is prominent, as it is a key…
